KBC Group
PRCT icon

KBC Group’s Procept Biorobotics PRCT Stock Holding History

KBC Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43K Hold
1,713
– – ﹤0.01% 1708
2025
Q4 		$54K Hold
1,713
– – ﹤0.01% 1615
2025
Q3 		$61K Hold
1,713
– – ﹤0.01% 1567
2025
Q2 		$99K Sell
1,713
-523
-23% -$29.6K ﹤0.01% 1211
2025
Q1 		$130K Hold
2,236
– – ﹤0.01% 1334
2024
Q4 		$180K Buy
2,236
+705
+46% +$60.2K ﹤0.01% 1190
2024
Q3 		$123K Buy
1,531
+376
+33% +$26.7K ﹤0.01% 1156
2024
Q2 		$71K Hold
1,155
– – ﹤0.01% 1405
2024
Q1 		$57K Buy
+1,155
New +$55K ﹤0.01% 1473

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KBC Group's PRCT Position: Q1 2026 in Review

KBC Group held its Procept Biorobotics (PRCT) position steady in Q1 2026 at 1,713 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

KBC Group first reported a position in PRCT in Q1 2024 and has held it in 9 quarters since. The position peaked at $180K in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • KBC Group held 1,713 shares of Procept Biorobotics worth $43K as of Q1 2026.
  • KBC Group left its Procept Biorobotics share count unchanged in Q1 2026.
  • Procept Biorobotics made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1708 holding.
  • KBC Group first reported a position in Procept Biorobotics in Q1 2024 and has held it in 9 quarters since.
  • KBC Group's Procept Biorobotics position peaked at $180K in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.